Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: BHP Falls After Earnings Miss Expectations

Tue, 20th Aug 2019 10:28

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------J Sainsbury, up 2.5%, Ocado Group, up 2.4%. The UK grocery market was flat in the past three months due to "tough" comparatives with last year's hot summer, a survey by Kantar Worldpanel showed. In the 12 weeks to August 11, supermarket sales were flat compared to a year before, Kantar said. Ocado claimed the top spot as the UK's fastest growing grocer, increasing sales by 13% during the period. The online grocer increased its shopper base by 7% and encouraged its customers to spend GBP1.93 more each delivery, Kantar noted. Sainsbury's accounted for 15.4% of all UK supermarket sales during the 12-week period. Overall Sainsbury's sales fell by 0.6%, however, despite sales of branded goods rising by 1.5%, driven by higher levels of promotion and Sainsbury's price lockdown strategy.----------Antofagasta, up 1.9%. Goldman Sachs raised the copper miner to Neutral from Sell. ----------AstraZeneca, up 1.7%. The Anglo-Swedish drugmaker reported positive results from the third phase of the DAPA-HF trial. Astra said the study showed Farxiga met the primary composite endpoint with a reduction of cardiovascular death or the worsening of heart failure, compared to a placebo.----------FTSE 100 - LOSERS----------Rentokil Initial, down 2.0%. RBC Capital cut the pest control company to Sector Perform from Outperform. ----------BHP Group, down 1.0%. The Anglo-Australian miner reported an improvement in performance in its most recently ended financial year, but results were mostly below what the market had expected. For the 12 months to June, the mining giant's pretax profit rose 2.0% to USD15.05 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation were broadly flat year-on-year at USD23.16 billion compared to USD23.18 billion. The underlying Ebitda figure fell short of the USD23.71 billion expected by analysts. BHP's annual revenue from continuing operations was USD44.29 billion, up 2.7% from a year earlier, but again below consensus of USD44.74 billion. "The current negative backdrop would suggest BHP may find it hard to keep growing earnings at the current rate, particularly in the short term," noted AJ Bell's Russ Mould. ----------FTSE 250 - WINNERS----------Mitchells & Butlers, up 3.2%. Canaccord upgraded the pub and restaurant operator to Buy from Hold. ----------IMI, up 1.7%. The engineer IMI announced the USD85 million acquisition of Pennsylvania-based valve and flow control product maker PBM. PBM will join IMI's Critical Engineering division, and IMI said the deal is an "important opportunity" to broaden into an "attractive, adjacent market". PBM registered USD6.8 million of adjusted earnings before interest, tax, depreciation, and amortisation in 2018, on revenue of USD35.6 million. By comparison, FTSE 250-listed IMI delivered revenue of GBP1.91 billion.----------FTSE 250 - LOSERS----------Ashmore Group, down 2.8%. Exane BNP cut the emerging markets-focused asset manager to Neutral from Outperform. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Avesoro Resources, up 27% at 87.70p. Shares in the miner climbed after it said its major shareholder is considering a buyout. The firm is also considering a review of the Youga gold mine, and has suspended guidance due to ongoing problems both at Youga and the New Liberty mine. Avesoro Jersey currently owns 73% of Avesoro, and the company has now said a "non-binding expression of interest" has been made to buy the rest of Avesoro's shares at 100 pence each. The company said shareholders owning 13% of Avesoro have already supported the move. Avesoro Jersey is led by Avesoro Non-Executive Chair Murathan Gunal, a Turkish businessman. On the operational front, Avesoro is now assessing the long-term viability of Burkina Faso's Youga gold mine. Last Wednesday night, a security guard at the mine shot dead a clandestine miner at Youga, which led to a break-in by an armed group of fellow artisanal miners. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Mysale Group, down 47% at 2.5p. The online retailer said it intends to raise at least GBP10.0 million before expenses from a share placing. The online retailer said the placing will enable it to repay its bank debt, meaning that it will operate on a debt-free basis, improving cash flow. The fundraising also will support the restructuring of MySale into an Australia and New Zealand-focused retail marketplace platform - what it calls its "ANZ First" strategy. Some 79% of MySale shareholders have supported the placing of 500.0 million shares at a price of 2.0 pence each. The placing price represents a discount of 58% to the closing price of 4.75 pence on Monday. Looking forward, MySale proposed an open offer for up to a further GBP2.0 million to be launched in due course.----------

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.